Elaine Shi
About Elaine Shi
Elaine Shi is the Development Program Lead/VP at Bristol Myers Squibb in Summit, New Jersey, with nearly two decades of experience in drug development and expertise in oncology and hematology.
Current Role at Bristol Myers Squibb
Elaine Shi currently holds the position of Development Program Lead/VP at Bristol Myers Squibb. Based in Summit, New Jersey, her role involves overseeing development programs, ensuring strategic alignment with organizational goals, and managing cross-functional teams to deliver on drug development milestones. Her work at Bristol Myers Squibb leverages her extensive experience in drug development and commercialization.
Previous Tenure at Celgene
Elaine Shi has an extensive background with Celgene, where she progressed through several key roles over nearly a decade. She served as Executive Director Project Leadership from 2018 to 2019, Senior Director Project Leadership from 2014 to 2018, Director of Project Management from 2011 to 2014, and Associate Director Project Management from 2008 to 2011. During her time at Celgene, she was instrumental in leading project teams and driving strategic initiatives across various stages of drug development.
Management Roles at Novartis and PRTM
Prior to her tenure at Celgene, Elaine Shi worked at Novartis as Senior Project Manager in New Jersey from 2006 to 2008. Her responsibilities included managing complex projects and driving the development of pharmaceutical products. Before Novartis, she spent three years as a Management Consultant at PRTM in Stamford, CT, specializing in the pharmaceutical industry. Her role focused on consulting with pharmaceutical companies to optimize their project management processes.
Educational Background
Elaine Shi has a strong educational foundation in chemical engineering and business management. She earned a Bachelor of Science in Chemical Engineering from the Massachusetts Institute of Technology (MIT) from 1994 to 1997. She went on to receive her Master of Business Administration from the Northwestern University - Kellogg School of Management, focusing on strategy and finance, from 2001 to 2003. Her educational background has provided her with the technical and strategic skills necessary for her roles in the pharmaceutical industry.
Industry Expertise and Achievements
Elaine Shi boasts nearly two decades of experience in drug development, covering all phases from phase I through III and commercialization. Her expertise spans small molecules and cell therapy across multiple disease areas, including oncology and hematology. She has led global submissions and approvals for multiple billion-dollar assets, demonstrating her ability to navigate complex regulatory environments and achieve significant milestones. Known for her strategic and analytical thinking, strong interpersonal skills, and problem-solving abilities, she has successfully managed cross-functional teams and developed comprehensive life cycle management plans for approved therapies.